Making the world's first agentic biocomputer to simulate the complexity of life.

We're a AI research company, founded in 2024, dedicated to advancing next-generation, off-the-shelf agentic biocomputer to accelerate foundational biological discovery and automated modification. Our platform support a wide range of applications, including antibody development, protein engineering, gene therapy, T cell receptors, chimeric antigen receptors, stem cell and allogeneic cell therapy development for laboratory use.

Our technology relies on cutting-edge providers, scientific computing platforms

Magic Intelligence in the Sky

Cibo-1Physics-Based Agentic Computer for Life Sciences

Life is built from molecules, organized into proteins, encoded by genes, and formed into cells — now decoded and understood through the lens of bits, neurons, and qubits.

We are building substrate of the future of computing for biological life. We believe we are at the forefront of translating advanced biological capabilities into safe transformative solutions for the life sciences.

Origin: Developed by Frontier Evo, Co., Cibo-1 harnessing the power of agentic AI-native capabilities.
Functionality: Cibo-1 is agentic biocomputer that burning physics-based computing into life sciences research. Through accelerated, hardware-aware algorithms and semi-recursive processing techniques, it brings unparalleled efficiency to research workloads in biology and life sciences.
Objective: Cibo-1 is engineered to usher in an era of practical agentic advantage, revolutionizing the life sciences with faster, more precise biological and chemical alignment capabilities for research applications.
Interface: A natural-language interface empowers scientists to intuitively engage with Cibo-1’s functionalities. This seamless interaction removes the need for complex setup, allowing researchers to perform simulations, data analysis, and modeling directly in natural language.
Key Features: Control specialized Biocomputing Functional Modules (bFMs) to conduct research and leverage advanced computational functions. Generate predictions for proteins, small molecules, DNA, RNA, covalent modifications, CAR-T cell receptors (CAR-TCRs), and more. Plot, clean, and analyze extensive datasets with ease. Employ recursive reasoning to continuously enhance computational performance across workloads.
Specialized-Focus: Designed for breakthroughs in Protein Science, Genetics, Cell Engineering and Genomics. Directly control bFMs from sequences, enhance Cibo-1 with raw data, multimodal data, such as lab-derived restraints, increasing performance improvements of over 14.6%.
Release: Early 2025, first release of Cibo-1.